TrueBlue, Inc. (NYSE:TBI) Shares Sold by Quadrature Capital Ltd

Quadrature Capital Ltd cut its holdings in shares of TrueBlue, Inc. (NYSE:TBIFree Report) by 66.3% during the third quarter, Holdings Channel.com reports. The fund owned 11,202 shares of the business services provider’s stock after selling 22,009 shares during the period. Quadrature Capital Ltd’s holdings in TrueBlue were worth $88,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD lifted its stake in TrueBlue by 25.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 36,983 shares of the business services provider’s stock worth $464,000 after purchasing an additional 7,417 shares in the last quarter. Assenagon Asset Management S.A. raised its position in TrueBlue by 3.1% in the second quarter. Assenagon Asset Management S.A. now owns 290,360 shares of the business services provider’s stock valued at $2,991,000 after purchasing an additional 8,669 shares during the period. Bank of New York Mellon Corp raised its position in TrueBlue by 2.3% in the second quarter. Bank of New York Mellon Corp now owns 130,200 shares of the business services provider’s stock valued at $1,341,000 after purchasing an additional 2,905 shares during the period. Azarias Capital Management L.P. raised its position in TrueBlue by 40.8% in the second quarter. Azarias Capital Management L.P. now owns 1,247,222 shares of the business services provider’s stock valued at $12,846,000 after purchasing an additional 361,101 shares during the period. Finally, nVerses Capital LLC acquired a new stake in shares of TrueBlue in the second quarter valued at $35,000. 97.15% of the stock is currently owned by institutional investors and hedge funds.

TrueBlue Stock Performance

TBI stock opened at $8.83 on Friday. The stock has a market capitalization of $261.01 million, a P/E ratio of -2.30 and a beta of 1.47. TrueBlue, Inc. has a one year low of $6.63 and a one year high of $16.14. The company has a 50 day moving average price of $7.58 and a two-hundred day moving average price of $8.74.

TrueBlue (NYSE:TBIGet Free Report) last announced its quarterly earnings data on Monday, November 4th. The business services provider reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.04. The company had revenue of $382.36 million during the quarter, compared to analysts’ expectations of $386.07 million. TrueBlue had a negative net margin of 6.97% and a negative return on equity of 2.69%. The business’s quarterly revenue was down 19.2% compared to the same quarter last year. During the same period in the previous year, the company earned $0.16 EPS. Research analysts forecast that TrueBlue, Inc. will post -0.56 earnings per share for the current fiscal year.

Analyst Ratings Changes

TBI has been the topic of several recent analyst reports. BMO Capital Markets dropped their target price on TrueBlue from $11.00 to $10.00 and set an “outperform” rating on the stock in a report on Tuesday, November 5th. StockNews.com upgraded shares of TrueBlue from a “sell” rating to a “hold” rating in a research report on Tuesday.

Read Our Latest Research Report on TrueBlue

TrueBlue Company Profile

(Free Report)

TrueBlue, Inc, together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries.

See Also

Want to see what other hedge funds are holding TBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TrueBlue, Inc. (NYSE:TBIFree Report).

Institutional Ownership by Quarter for TrueBlue (NYSE:TBI)

Receive News & Ratings for TrueBlue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TrueBlue and related companies with MarketBeat.com's FREE daily email newsletter.